MARTINELLI, SERENA
 Distribuzione geografica
Continente #
EU - Europa 905
NA - Nord America 796
AS - Asia 205
AF - Africa 2
OC - Oceania 1
Totale 1.909
Nazione #
US - Stati Uniti d'America 791
RU - Federazione Russa 365
PL - Polonia 266
IT - Italia 103
SG - Singapore 77
IE - Irlanda 50
HK - Hong Kong 49
SE - Svezia 47
CN - Cina 46
GB - Regno Unito 18
FI - Finlandia 17
IN - India 14
CH - Svizzera 13
DE - Germania 12
JO - Giordania 9
BE - Belgio 8
VN - Vietnam 6
CA - Canada 5
NL - Olanda 4
KR - Corea 3
CI - Costa d'Avorio 2
AT - Austria 1
AU - Australia 1
KG - Kirghizistan 1
RO - Romania 1
Totale 1.909
Città #
Warsaw 266
Santa Clara 208
Fairfield 70
Singapore 69
Ann Arbor 50
Dublin 50
Ashburn 49
Woodbridge 43
Chandler 41
Hong Kong 40
Seattle 35
Florence 32
Houston 28
Cambridge 27
Moscow 26
Wilmington 20
Lawrence 13
Altamura 12
Beijing 12
Shanghai 12
Bern 11
Helsinki 11
Kent 11
Buffalo 10
Mumbai 10
Princeton 10
Boston 8
Brussels 8
New York 8
West Jordan 8
Dong Ket 6
Bremen 5
San Diego 5
Boardman 4
Fiesole 4
Lappeenranta 4
Medford 4
Milan 4
Redmond 4
Redwood City 4
Shenzhen 4
Xi'an 4
Yubileyny 4
Fontebuona 3
Los Angeles 3
Ottawa 3
Pune 3
Seoul 3
Abidjan 2
Andover 2
Biloxi 2
Hillsboro 2
Phoenix 2
Pisa 2
Prato 2
Rome 2
San Giovanni Valdarno 2
Schweinfurt 2
Toronto 2
Volketswil / Volketswil (Dorf) 2
Bangalore 1
Bishkek 1
Bologna 1
Casapulla 1
Chiswick 1
Falls Church 1
Foshan 1
Frankfurt am Main 1
Fucecchio 1
Gonnoscodina 1
Harbin 1
Heze 1
Kilburn 1
Langhirano 1
London 1
Melbourne 1
Nuremberg 1
Nürnberg 1
Orlando 1
Scarperia 1
Schiavon 1
Sezze 1
Turin 1
Wuhan 1
Zhoukou 1
Totale 1.318
Nome #
mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms. 253
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 227
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/ CIP2A axis 178
Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. 127
A unique neuroendocrine cell model derived from the human foetal neural crest. 122
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 111
Low sodium and tolvaptan have opposite effects in human small cell lung cancer cells 79
Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells 77
SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism 75
Pheochromocytoma/paraganglioma preclinical models: which to use and why? 70
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 69
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 59
Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts 57
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 56
The regulatory effect of sex steroids on the RhoA/ROCK pathway in the rat distal vagina 51
Tumour microenvironment in pheochromocytoma and paraganglioma 51
The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide 48
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 43
Synergistic Strategies for Gastrointestinal Cancer Care: Unveiling the Benefits of Immunonutrition and Microbiota Modulation 41
Microbiota Transplant and Gynecological Disorders: The Bridge between Present and Future Treatments 37
The Impact of Microbiota–Immunity–Hormone Interactions on Autoimmune Diseases and Infection 37
Anatomical and functional changes of the fetal adrenal gland in intrauterine growth restriction 33
Does microbiota composition act as predictive signature for the evaluation of chemoimmunotherapy response efficacy? 29
Distal vagina smooth muscle contractility mechanisms: effects of in vivo sex steroids treatment in an animal experimental model of ovariectomy 23
Totale 1.953
Categoria #
all - tutte 6.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020159 0 0 0 0 22 16 18 29 26 18 30 0
2020/2021187 13 20 6 20 9 41 8 13 17 23 4 13
2021/202296 3 3 12 1 3 5 1 16 5 11 13 23
2022/2023247 15 46 16 22 10 43 35 11 20 9 8 12
2023/2024228 5 18 19 18 13 15 8 52 29 25 18 8
2024/2025766 39 144 79 229 275 0 0 0 0 0 0 0
Totale 1.953